Free Trial

Pediatrix Medical Group (MD) SEC Filings & 10K Form

Pediatrix Medical Group logo
$13.78 0.00 (0.00%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$13.78 0.00 (-0.04%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Pediatrix Medical Group SEC Filings

DateFilerForm TypeView
07/01/2025
3:30 PM
Pediatrix Medical Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
4:10 PM
ALLIANCEBERNSTEIN L.P. (Filed by)
Pediatrix Medical Group (Subject)
Form SCHEDULE 13G/A
05/08/2025
3:30 PM
Pediatrix Medical Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
5:50 AM
Pediatrix Medical Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
6:00 AM
Pediatrix Medical Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/28/2025
5:52 AM
Pediatrix Medical Group (Filer)
Form DEF 14A
03/28/2025
5:54 AM
Pediatrix Medical Group (Filer)
Form DEFA14A
03/28/2025
5:55 AM
Pediatrix Medical Group (Filer)
Form ARS
02/20/2025
6:00 AM
Pediatrix Medical Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2025
5:50 AM
Pediatrix Medical Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
4:30 PM
ORDAN MARK S (Reporting)
Pediatrix Medical Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:30 PM
Pediatrix Medical Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
5:50 AM
Pediatrix Medical Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:30 PM
Pediatrix Medical Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
4:00 PM
Pediatrix Medical Group (Issuer)
Rossi Kasandra H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:00 PM
ORDAN MARK S (Reporting)
Pediatrix Medical Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
4:00 PM
Moore Mary Ann E (Reporting)
Pediatrix Medical Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:01 PM
Moore Mary Ann E (Reporting)
Pediatrix Medical Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
6:00 AM
Pediatrix Medical Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
5:50 AM
Pediatrix Medical Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
10:54 AM
DIMENSIONAL FUND ADVISORS LP (Filed by)
Pediatrix Medical Group (Subject)
Form SC 13G/A
10/04/2024
4:00 PM
Pediatrix Medical Group (Issuer)
Rossi Kasandra H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/30/2024
3:09 PM
Pediatrix Medical Group (Subject)
Swift James D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
4:00 PM
Linynsky Laura A (Reporting)
Pediatrix Medical Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:03 PM
Linynsky Laura A (Reporting)
Pediatrix Medical Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:34 PM
Pediatrix Medical Group (Subject)
Wood Lee (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:29 PM
Pediatrix Medical Group (Subject)
Richards C Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
5:50 AM
Pediatrix Medical Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:00 AM
Pediatrix Medical Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:MD) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners